Skip to main content
Clinical Trials/NCT07655895
NCT07655895Active, not recruitingNot Applicable

Sublingual Neonatal Incision Platform (SNIP) Case Series

Europa Life Sciences Limited1 site in 1 country6 target enrollmentStarted: March 10, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
6
Locations
1

Study Overview

Brief Summary

A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
1 Week to 12 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Anterior ankyloglossia requiring intervention

Exclusion Criteria

  • Concomitant morphological variation in the oral cavity which could compromise frenectomy Blood dyscrasia Immunocompromise

Investigators

Sponsor
Europa Life Sciences Limited
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Case Series of Infants With Anterior... | Clinical Trial